|
Re: A MUST READ--get the word out--to governments, bean-counters, insurance companies
Understand Lani, but we can also realize that the authors also have knoweldge since they do work for the company. For instance before the FDA approved Herceptin for early stage I would strongly think that the company was confident that early stage patients should be on the treatment...and that was years prior to the
approval. No matter who works where...it is my belief
that Herceptin saves many from recurrence. Certainly we do not have all the answers yet as to why some who are treated with herceptin fail - while others remain free of cancer...hopefully those answers will come in the near future. I met a women who was in the first trials of early stage patients who were lucky to have herceptin....she will be 10 yrs. out in a few months. and she is doing great. Was this due to the herceptin or would she never have recurred? We do know now that hercpetin does help (not all) but I will grab onto that for the time being.
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
Last edited by Jean; 08-26-2010 at 03:25 AM..
|